Introduction {#s1}
============

Obstructive sleep apnoea (OSA) is a highly prevalent chronic disease with serious morbidity associations and hence poses a major burden on the health system \[[@C1]\]. Continuous positive airway pressure (CPAP), the treatment of choice for OSA, is very effective but unfortunately suboptimal patient adherence to CPAP is common, as up to half of OSA patients either reject or discontinue CPAP within the first weeks. Accordingly, CPAP compliance represents a major challenge for sleep specialists \[[@C2], [@C3]\]. Hence, strategic changes towards more cost-effective methods for managing the treatment of OSA with CPAP are urgently needed. As recently suggested, the use of telemedicine has significant potential for the management of patients with OSA \[[@C4]--[@C6]\].

Several clinical trials have demonstrated the feasibility of telemedicine-based OSA management compared with a more traditional, in-person care model, suggesting noninferiority in terms of adherence to CPAP treatment \[[@C7]\], CPAP compliance \[[@C8]\] as well as functional outcomes such as satisfaction \[[@C9]\] and cost-effectiveness \[[@C10], [@C11]\]. In our previous experience using telemedicine for OSA management, we found positive feedback with videoconference and mobile health (mHealth) interventions \[[@C12], [@C13]\]. We also conducted a telemedicine-based strategy for CPAP follow-up which was as effective as standard hospital-based care in terms of CPAP compliance and symptoms improvement, as well as lower costs \[[@C11]\].

Nevertheless, technological innovations in healthcare can be potentially disadvantageous if they are not properly applied or understood, a phenomenon we have previously described as the "technological labyrinth syndrome" \[[@C14]\], basically referring to a process which is too complex for patients to follow or excessively time consuming for healthcare personal to follow-up. Therefore, it seems imperative that any new technology applied for health purposes is fundamentally simple, easy to use, reliable and transparent, and able to control or contact with the patient. mHealth is a modality of telemedicine that delivers a promising approach for patients through the use of portable devices such as smartphones and tablets for medical purposes, including treatment follow-up and support of general health. By means of mobile apps, patients' input can be gathered from interactive questionnaires and processed by specific algorithms to generate customised treatment recommendations \[[@C15]\]. From previous work we found that simple mHealth interventions are well received by patients and seem promising to improve CPAP compliance among patients with OSA \[[@C13]\]. mHealth is currently on the rise, following the wide spread of the internet and mobile devices. Given the increase in the development of mHealth apps, the potential reach and impact over health promotion have never been greater. Additionally, the potential impact on healthcare cost reductions should be considered as a positive outcome of using mHealth \[[@C4]\]. Nevertheless, further extensive studies are needed, and the opinions of both healthcare professionals and patients are essential before moving forward in the clinical implementation of telemedicine strategies \[[@C16]\].

Therefore, we have now designed an innovative mobile app called Appnea-Q (Appnea-Questions) with new functionalities that deliver a self-monitoring tool for OSA patients treated with CPAP aimed to promote easy and remote clinical control. So far, numerous providers have developed tools for CPAP monitoring mainly focused on the technological aspects of treatment, neglecting the clinical aspects of OSA patients treated with CPAP, which is of paramount importance during follow-up to ensure appropriate adaptation and compliance to the treatment. Previous work from the Spanish Sleep Network suggests a better CPAP compliance (\>5.6 h·night^−1^) might help reduce the deleterious cardiovascular effects of OSA \[[@C17]\]. Here, we describe the features of the app, and evaluate its feasibility and acceptance by current OSA patients treated with CPAP and by professionals specialised in sleep medicine.

Materials and methods {#s2}
=====================

Mobile application: patient interface {#s2a}
-------------------------------------

Appnea-Q requires the patient to login with a personal username and password for data recognition and privacy protection. Compared with our previous work in mHealth \[[@C13]\], in this app we have incorporated new features and more information focused on the patient\'s needs to deliver a self-monitoring tool divided into three main sections: 1) follow-up questionnaire, 2) frequent problems and 3) recommendations ([figure 1](#F1){ref-type="fig"}).

![a) Appnea-Q smartphone access and patient password-protected login screen and b) main screen, divided into three sections: 1) follow-up questionnaire, 2) frequent problems and 3) recommendations. CPAP: continuous positive airway pressure. The original text in Spanish has been translated into English.](00220-2019.01){#F1}

The follow-up questionnaire section of Appnea-Q consists of 10 questions in total, nine of them single-choice questions (Yes/No) divided into the following aspects of treatment: CPAP use and effectiveness (Questions 1--3), common side-effects (Questions 4--6), exercise and diet (Questions 7--9), and a final question to fill in the patient\'s current weight (Question 10). In addition, Appnea-Q provides automated feedback according to the patient\'s answers. Nonsatisfactory answers receive useful advice, while positive answers receive an encouraging message ([figure 2](#F2){ref-type="fig"} and [supplementary table S1](http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00220-2019.figures-only#fig-data-supplementary-materials)). Patients can receive periodic reminders set by the physician to complete the questionnaire, as often as needed.

![Example follow-up question: automated answers give advice to patients. CPAP: continuous positive airway pressure. The original text in Spanish has been translated into English.](00220-2019.02){#F2}

The frequent problems section of Appnea-Q summarises the most common side-effects and issues faced by CPAP patients during the course of the treatment (*e.g.* dry mouth, air leaks and nasal congestion) ([supplementary figure S1](http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00220-2019.figures-only#fig-data-supplementary-materials)). The main goal is to provide useful solutions, with the patient being allowed to consult at any time a problem arises, gaining valuable time and supporting their CPAP therapy. In case the problem is not resolved, a voicemail contact is provided so patients can deliver consultations that will be attended by the sleep unit nurses within 24--48 h.

In the recommendations section, Appnea-Q users can find general information concerning CPAP use, sleep hygiene rules and diet information. This information is aimed at promoting an integral and more effective treatment approach to OSA. All components in the app have been specifically designed by our team of specialised nurses and physicians.

The Spanish version of Appnea-Q is available for free download on Android platforms *via* Google Play and for iOS, respectively:

<https://play.google.com/store/apps/details?id=net.bdevelopments.appneaQuestions> and <https://itunes.apple.com/us/app/appneaquestions/id1404229790?platform=iphone&preserveScrollPosition=true&platform=iphone#platform/iphone&platform=iphone>

Web platform: sleep care professionals {#s2b}
--------------------------------------

We designed a password-protected web platform where sleep professionals can login from their sleep unit. The app content can be accessed with a username and password registered by hospital professionals only. Connections to the server are made under a secure SSL connection protocol, which means that the information transmitted is encrypted. Professionals can create as many personal users as they need, for those patients they decide to monitor through the app. Each patient is categorised by the sleep unit that is attending him/her. The sleep professional can review the information gathered from all their patients\' questionnaires on this web platform, and a filter is applied so those with nonsatisfactory responses will appear at the top of the patients list and will be marked in red, allowing the hospital professional to easily identify patients in need of early assistance ([supplementary figure S2](http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00220-2019.figures-only#fig-data-supplementary-materials)). Once the questionnaire has been reviewed, the patient\'s name is returned to the chronological order it was created.

Feasibility and acceptance of Appnea-Q {#s2c}
--------------------------------------

This trial was conducted in the Hospital Clínic (Barcelona, Spain), where it was approved by the relevant Ethics Committee. To evaluate the feasibility and acceptance of Appnea-Q, 75 consecutive patients on CPAP follow-up consultations were asked to use the app during the visit, answering the questionnaire and exploring the frequent problems and recommendations sections. Patients were recruited from two tertiary hospitals. All patients received a personal username and password to sign up, and their answers were tracked by the professionals' web platform. After testing the app, all patients completed a System Usability Scale (SUS), a Likert-type scale used to assess the user\'s subjective view of the app usability \[[@C18]\], followed by a questionnaire on the level of satisfaction with the app content. An external validation was also performed in 15 out of the 75 patients recruited, installing the app on their own smartphone and asking them to use it during 3 consecutive days, tracking patients\' answers to the follow-up questionnaires and submitting a satisfaction survey afterwards.

Additionally, sleep healthcare professionals were recruited from 15 different sleep units from all over Spain. All specialised sleep physicians and nurses/technicians were asked to explore Appnea-Q and answer a short survey on its usability to follow-up OSA patients. A descriptive analysis was conducted. Quantitative variables were assessed by calculating the arithmetic mean and standard deviation. For qualitative variables, percentages were calculated.

Results {#s3}
=======

Internal validation {#s3a}
-------------------

### Patients {#s3a1}

75 patients with OSA under CPAP treatment were enrolled. Most of the patients were male (84%), with middle to superior studies (81.33%) and reported frequent use of smartphones (85.33%); their baseline characteristics are summarised in [table 1](#TB1){ref-type="table"}. Only five patients had trouble completing the questionnaire. Remarkably, they were all aged \>75 years old. Only three patients could not finalise the questionnaire because of a technical failure when introducing their weight. SUS score was rated on the subjective scale as good; according to the assessments of the usability scale it was rated as acceptable with a score of 79.37±19.29 and a 50th percentile of 82.5. Moreover, on a linear scale from 1 to 10, the utility of Appnea-Q was rated at 7.70.

###### 

Baseline patient characteristics

  --------------------------------- -------------
  **Patients**                           75
  **Male**                            63 (84.0)
  **Age years**                      61.91±10.33
  **BMI kg·m^−2^**                   32.61±7.06
  **AHI events·h^−1^**               52.29±19.36
  **CPAP compliance h·night^−1^**     5.70±2.34
  **Middle to superior studies**      61 (81.3)
  **Frequent use of smartphones**     64 (85.3)
  --------------------------------- -------------

Data are presented as n, n (%) or mean±[sd]{.smallcaps}. BMI: body mass index, AHI: apnoea--hypopnoea index; CPAP: continuous positive airway pressure.

When evaluating Appnea-Q content, 75 patients answered the satisfaction survey; most considered that the different app sections were useful. Specifically, the frequent problems section was considered the most useful (88%), followed by the diet, healthy sleep and CPAP use section (82.67%), and automated questionnaire answers (74%). Additionally, most of the patients would recommend the app to other users (86.49%) and considered it useful to control their OSA condition (73.33%). Moreover, in relation to the capacity of Appnea-Q to reduce hospital visits, 64.87% agreed, while the rest were not sure (22.97%) or did not consider it possible (12.16%). The patients\' survey is summarised in [table 2](#TB2){ref-type="table"}.

###### 

Patients\' survey on Appnea-Q

  ---------------------------------------------------------------------------------- -----------
  **Subjects**                                                                           75
  **Did you find the automatic answers of the questionnaire helpful?**               
   Yes                                                                                54 (72.0)
   Partially                                                                          18 (24.0)
   No                                                                                  3 (4.0)
  **Did you find the frequent problems section useful?**                             
   Yes                                                                                66 (88.0)
   Partially                                                                          8 (10.7)
   No                                                                                  1 (1.3)
  **Did you find the dietary, sleep/health and CPAP tips helpful?**                  
   Yes                                                                                62 (82.7)
   Partially                                                                          13 (17.3)
   No                                                                                     0
  **Would you recommend this app to other people?**                                  
   Yes                                                                                64 (86.5)
   No                                                                                  4 (5.4)
   Don\'t know                                                                         6 (8.1)
  **Do you think the app could help reduce the number of visits to the hospital?**   
   Yes                                                                                48 (64.9)
   No                                                                                 9 (12.2)
   Don\'t know                                                                        17 (23.0)
  **Would you like to use this app for your control of sleep apnoeas?**              
   Yes                                                                                55 (73.3)
   No                                                                                  6 (8.0)
   Don\'t know                                                                        14 (18.7)
  ---------------------------------------------------------------------------------- -----------

Data are presented as n or n (%); percentages may not total 100% due to rounding. CPAP: continuous positive airway pressure.

### Professionals {#s3a2}

30 healthcare professionals specialised in sleep respiratory medicine (physicians n=17 and nurses/technicians n=13) from different sleep units all over Spain explored Appnea-Q and then answered a short survey ([table 3](#TB3){ref-type="table"}). They all concurred that Appnea-Q would be useful to provide OSA patient control and follow-up, particularly during the first month of CPAP therapy initiation, and routine follow-up as a second option. They also agreed that the app could reduce the number of hospital visits. Neither physicians nor nurses/technicians showed major concerns about the risk of workplace reduction as a consequence of incorporating the app in the clinical routine (results are summarised in [table 3](#TB3){ref-type="table"}).

###### 

Sleep healthcare professionals\' survey on Appnea-Q usefulness and impact on hospital visits and workplaces

                                                                                                                   **Sleep physicians**   **Sleep nurses/technicians**
  --------------------------------------------------------------------------------------------------------------- ---------------------- ------------------------------
  **Subjects**                                                                                                              17                         13
  **Do you think that this app can be useful for control and monitoring of patients with sleep apnoea?**                                 
   Yes                                                                                                                   17 (100)                  12 (92.3)
   No                                                                                                                       0                       1 (7.7)
   Don\'t know                                                                                                              0                          0
  **Do you think that using this app could reduce the number of hospital visits?**                                                       
   Yes                                                                                                                  11 (64.7)                   9 (69.2)
   No                                                                                                                       0                       1 (7.7)
   Don\'t know                                                                                                           6 (35.3)                   3 (23.1)
  **In what situations do you think this app could be useful? (Multiple choices)**                                                       
   First month of CPAP treatment                                                                                        15 (88.2)                  12 (92.3)
   Non-compliant patients                                                                                                4 (23.5)                   3 (23.1)
   Routine follow-up                                                                                                     8 (47.1)                   7 (53.8)
  **Do you think that this system can reduce jobs because of more telematic contact but less hospital visits?**                          
   Yes                                                                                                                   2 (11.8)                   2 (15.4)
   No                                                                                                                   10 (58.8)                   6 (46.1)
   Don\'t know                                                                                                           5 (29.4)                   5 (38.5)

Data are presented as n or n (%); percentages may not total 100% due to rounding. CPAP: continuous positive airway pressure.

External validation: patients {#s3b}
-----------------------------

An external validation was performed in a subgroup of 15 patients (out of the original 75 patients) that used the app for 3 consecutive days in their home. All were male, mean age 61.2±7.68 years, apnoea--hypopnoea index 45±21.37 events·h^−1^, CPAP use 5.67±3.20 h·night^−1^ and 86.66% with middle to superior studies, and all 15 reported frequent use of smartphones. Their mean SUS score was 85.17±14.25; rated on the subjective scale as excellent and on the usability scale as acceptable. 11 out of 15 patients completed the follow-up questionnaire of the first day and second day, and nine out of 15 patients also completed the follow-up questionnaire of the third day. Data were received accordingly on the professionals\' web platform. Additionally, the satisfaction survey for this group included a question regarding the periodicity over which they wished to answer the questionnaire during their CPAP therapy follow-up; the opinion was evenly divided between weekly, monthly or twice a week.

Discussion {#s4}
==========

Our findings suggest that the mobile app Appnea-Q is a feasible and well-received tool for OSA management according to patients and sleep professionals. On the one hand, the content and technological usability of the app was positively valued by OSA patients. On the other hand, healthcare professionals found the app could be useful to manage OSA patients and to reduce in-hospital visits, particularly during the first month of CPAP therapy.

Telemedicine and particularly mHealth are suitable strategies that could transform the healthcare approach by providing increased and anytime access to information, and empower patients to be informed, engaged and equipped to take part in shared decision making and effective self-management of chronic illnesses \[[@C19]\], shifting healthcare from a disease-centred to a patient-centred model \[[@C20]\]. The use of telemedicine to enhance CPAP follow-up is an area that has been most explored, but the optimal format, information and delivery mechanism are still unclear \[[@C21]\].

Our previous experiences in telemedicine and OSA management have involved a series of telemedicine strategies, a very enlightening process in the search for the most adequate strategy. Initially, patients were satisfied with videoconference interventions for CPAP follow-up consultation and CPAP training sessions \[[@C12]\]. Later, a telemedicine-based strategy for CPAP follow-up compared with in-hospital-based care revealed similar levels of CPAP compliance, and improved symptoms, side-effects, quality of life and degree of satisfaction. In addition, the telemedicine-based strategy had lower total costs due to savings on transport and less lost productivity \[[@C11]\]. Furthermore, we developed an early mHealth app which was shown to be feasible and satisfactory in OSA patients \[[@C13]\]. More recently, we evaluated patients\' perspective on a new management approach for CPAP titration encompassing both telemedicine and mHealth compared with in-hospital-based care. Using a focus group methodology, most patients described the telemedicine approach as an innovative, accessible and time-saving way to control their treatment, which was also found to be feasible in patients with limited knowledge of the use of the internet and mobile apps \[[@C22]\].

Consequently, our findings confirmed that the telemedicine patient\'s opinion is of paramount importance when designing future telemedicine procedures, and that these telemedicine approaches can also be troublesome if they are not properly validated and applied to the correct population targets. In fact, they could even increase mortality in certain groups \[[@C23]--[@C25]\]. Therefore, ease of use, usefulness, effectiveness, low cost and reliability are paramount in telemedicine interventions \[[@C23]\]. To that end, telemedicine interventions must be enlightened by more research on their usability by both patients and healthcare professionals \[[@C26]\]. Even though telemedicine is in general well accepted by OSA patients \[[@C27]\], recent work by T[urino]{.smallcaps} *et al.* \[[@C10]\] showed telemonitoring of CPAP signals alone did not improve CPAP treatment compliance and was associated with lower patient satisfaction. Moreover, from the professionals\' side there are well-known factors preventing the widespread implementation of this strategy, including poor organisation in healthcare institutions, regulations and clinical practice guidelines, and staff training. In addition, the accessibility to these resources and the sense of self-efficacy are also factors related to the use of telemedicine. One of the main resistance factors to the use of telemedicine is the idea from health professionals of a potential increase in work overload. However, different studies have shown that both the implementation of clear protocols and previous staff training have positive effects \[[@C28], [@C29]\]. Overcoming these resistance factors could open the door to a more pro-active telemedicine implementation, facilitating the decentralisation of services \[[@C4]\].

Currently, some CPAP device manufacturers provide mHealth web platforms allowing physicians and patients to remotely receive informative data such as compliance, apnoea--hypopnoea index and mask leaks, and present data in different ways (*e.g.* Encore Anywhere (Philips) and AirView (ResMed)). Moreover, each company employs its own proprietary algorithm, complicating the interpretation of results by health professionals \[[@C30]\]. Despite this technological aspect, which is certainly useful, personal interactions between patients and healthcare professionals are also essential in telemedicine interventions, since patient customisation is required \[[@C31]--[@C33]\]. In this context, Appnea-Q has been developed for personal interactions between patients and professionals to be useful in a significant number of subjects regardless of their phenotype.

Recently, H[wang]{.smallcaps} *et al*. \[[@C8]\] conducted a trial with 1455 OSA patients and found that combining two telemedicine (educational and telematics data) interventions increased CPAP usage to ∼4.8 h·night^−1^ compared with conventional treatment (∼3.8 h·night^−1^). However, such an ambitious approach does not distinguish the usefulness of the new intervention in specific patient groups. Hence, it seems wise to remain cautious and conduct targeted evaluations that help consolidate the role of telemedicine in routine CPAP follow-up \[[@C34]\]. Although supportive interventions are reported to increase usage in CPAP-naive patients, there is little evidence in people who have struggled with CPAP \[[@C35]\]. We must keep in mind that if telemedicine delivery to OSA patients' follow-up is efficacious it could have a potential impact on healthcare utilisation and a subsequent reduction in costs \[[@C36]\]. As these new telemedicine strategies are explored, it is of paramount importance that physicians see them as a manageable, reliable and safe asset to their practice. Meanwhile, patients\' technological barriers and quality concerns need to be openly faced and overcome to provide a simple and easy to use system \[[@C30]\].

In conclusion, our mobile app can be a well-received tool in the strategy to monitor and improve clinical control of the OSA patient\'s chronic condition and their therapy with CPAP, to encourage healthy lifestyles, with active participation of both patients and professionals. However, full clinical validation of this telemedicine strategy dedicated to OSA management is mandatory before its proper application into general routine practice.
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